Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic

P Krishnaswamy1, E Lubien, P Clopton

  • 1Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA.

Insights

A rapid B-natriuretic peptide test accurately identifies left ventricular dysfunction, correlating with echocardiography results. This can help determine if echocardiography is necessary for diagnosing heart conditions.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Imaging

Background:

  • Echocardiography is crucial for diagnosing left ventricular dysfunction but is limited by cost and availability.
  • B-Natriuretic peptide (BNP) levels reflect ventricular pressure and show promise in diagnosing heart failure.
  • Rapid BNP assays may offer a sensitive and specific alternative for screening.

Purpose of the Study:

  • To investigate the correlation between B-natriuretic peptide levels measured by a rapid assay and echocardiographic findings of ventricular dysfunction.
  • To determine if BNP levels can reliably predict the presence or absence of left ventricular abnormalities.

Main Methods:

  • 400 patients referred for echocardiography were studied.
  • B-natriuretic peptide levels were measured using a point-of-care immunoassay.
  • Patients were categorized based on echocardiographic findings: normal function, systolic dysfunction, diastolic dysfunction, or both.

Main Results:

  • Mean BNP levels were significantly higher in patients with abnormal left ventricular function (416 pg/mL) compared to those with normal function (30 pg/mL).
  • BNP levels showed a high accuracy (ROC curve area 0.95) in detecting any abnormal echocardiographic finding.
  • BNP levels could not differentiate between systolic and diastolic dysfunction but were highly predictive of diastolic abnormalities in symptomatic patients with normal systolic function.

Conclusions:

  • A rapid B-natriuretic peptide test reliably predicts left ventricular dysfunction identified by echocardiography.
  • Normal BNP levels may obviate the need for echocardiography in certain patient populations.
  • This rapid assay offers a valuable tool for assessing ventricular function and guiding diagnostic pathways.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.